Clinical trial to assess the effectiveness of honey to treat dry, sore, red eyes

October 13, 2014 by Sandra Hutchinson, Queensland University of Technology

Honey's antibacterial benefits are widely recognised but now a QUT team of optometry researchers is conducting clinical trials of the therapeutic effect of the sweet nectar as a remedy for dry, red and sore eyes, which are an irritating and chronic problem for one in three Australian adults.

Clinical Optometrist and researcher Dr Julie Albietz, from the QUT Health Clinics and the School of Optometry and Vision Sciences, has studied the benefits of antibacterial medical honeys on the eye's surface tissues for more than a decade and will lead two trials comparing traditional eye lid hygiene and lubricant eye products with honey-based therapies for the management of dry eye symptoms and signs.

"Dry eye disease, which commonly presents as red, sore and irritated eyes and blurry vision is a problem for about 30 per cent of adults," she said.

"It is primarily suffered by females, the elderly, individuals with autoimmune collagen vascular diseases, contact lens wearers, those using glaucoma eye drop medications and those who have recently undergone eye surgery."

Dr Albietz, who as part of her post-doctoral research at QUT pioneered the use of honey-based treatments for dry eye and other ocular surface diseases, said her studies had shown the use of honey offered significant benefits in treating eye problems.

Her research led to Australian company Melcare® developing and commercialising two Therapeutic Goods Administration-licensed honey-based products for eye care, both of which will be included in the clinical trials.

"There are a number of ways to treat chronic dry eye disease including the use of lubricating eye drops, ointments and gels, as well as antibiotic eye drops and steroids," she said.

"The problem with these treatments is that lubricants are insufficient in relieving dry eye symptoms and signs, antibiotics are toxic to the eye's surface tissues and can lead to development of resistance with prolonged use, and steroids have side effects including increased risk of eye infection.

"Now we have a safe, clinically effective, non-toxic alternative in the TGA-licensed Optimel® Antibacterial Manuka Eye Drops."

Dr Albietz said QUT would conduct two clinical trials to evaluate the effectiveness of antibacterial honey eye drops versus conventional lubricant and other clinic-based treatments.

"One is a pilot study involving participants who wear contact lenses but are struggling to remain in contact wear due to dry eye symptoms," she said

"The other is a large scale trial involving participants with meibomian gland dysfunction, or chronic red, inflamed eye lids and blocked oil glands in the eye lid margins which is a major cause of dry symptoms and signs."

Dr Albietz said one of the antibacterial benefits of honey was that bacteria could not grow in concentrated honey solutions, due to its acidity and high glucose concentration which created an unfavourable environment for bacteria to survive.

"Manuka Eye Drops have also demonstrated a reduction in inflammatory markers on the ocular surface.

"These anti-inflammatory effects of honey require further investigation as inflammation is a key factor in the development of and its chronic course."

Melcare chief executive Anthony Moloney said Optimel® Antibacterial Manuka Eye Drops contained a unique mix of honeys from Australian Leptospermum commonly called Manuka or Jelly Bush, which had all been selected for their high and consistent level of antibacterial benefits.

"We have developed two products, one that contains a concentrated level of honey and is only used by practitioners, and one that we have just released to the market which is a user-friendly Manuka honey saline drop available over the counter at pharmacies," he said.

"What we are producing in a world first is a high value natural product to help in the management of chronic dry disease," Mr Moloney said.

"These two products have been approved for sale in Australia and Europe, and there has been strong international interest from the US, China and the Middle East."

Mr Moloney said Melcare and Dr Albietz were also working on developing a honey-based product for sinus problems, or sinusitis, which often co-exist in individuals with chronic red, sore and irritated eyes.

Explore further: Around one in ten UK women has dry eye disease, requiring artificial tears

Related Stories

Around one in ten UK women has dry eye disease, requiring artificial tears

September 3, 2014
Around one in 10 women in the UK has dry eye disease, requiring artificial tears or gel to lubricate the eyes and protect them from damage, reveals the first UK research of its kind published online in the British Journal ...

New non-surgical treatment for common, vexing eye condition

March 31, 2014
A new report reveals a potential breakthrough in the treatment of a common eye ailment known as pterygium (Surfer's eye) that impacts the vision, eye health, and cosmetic appearance of countless sufferers.

Scientists 'see' the early cellular cause of dry eye disease for the first time

May 31, 2011
If you are one of the millions of people around the world who struggle with dry eye disease, good news is on the way. A new research discovery published in the Journal of Leukocyte Biology offers hope for new drugs that treat ...

Recommended for you

An orange a day keeps macular degeneration away: 15-year study

July 12, 2018
A new study has shown that people who regularly eat oranges are less likely to develop macular degeneration than people who do not eat oranges.

Injectable electronics offer powerful new tool in understanding how retinal cells work

June 28, 2018
Charles Lieber and his group are rewriting the rules of how scientists study retinal cells, and they're doing it with a single injection.

Why the eye could be the window to brain degeneration such as Alzheimer's disease

June 26, 2018
Researchers from Queen's University Belfast have shown for the first time that the eye could be a surrogate for brain degeneration like Alzheimer's disease (AD).

Microglia protect sensory cells needed for vision after retinal detachment

June 18, 2018
A research team at Massachusetts Eye and Ear has shown that microglia, the primary immune cells of the brain and retina, play a protective role in response to retinal detachment. Retinal detachment and subsequent degeneration ...

161 genetic factors for myopia identified

June 15, 2018
The international Consortium for Refractive Error and Myopia (CREAM) recently published the largest-ever genetic study of myopia in Nature Genetics. Researchers from the Gutenberg Health Study at the Medical Center of Johannes ...

Normal eye dominance is not necessary for restoring visual acuity in amblyopia

June 7, 2018
Amblyopia, commonly known as "lazy eye," is a visual disorder common in children. The symptoms often are low acuity in the affected or "lazy" eye and impaired depth perception. Researchers have long believed that the impaired ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.